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Objective. To evaluate rise in impedance during percutaneous radiofrequency thermocoagulation (PRFTC) of osteoid osteomas
as a predictor of local recurrence. Design and Patients. A prospective study of 23 patients (24 PRFTC procedures) with minimum
of 2.25-year followup (average 3.3 years). Average age 19.6 years (range 4–44), sex ratio 15:8 (male:female), 16 nondiaphyseal,
7 diaphyseal. Results. In 19 procedures, an increase in impedance was measured—no recurrences have occurred in this group to
date. In 5 procedures, no increase in impedance was seen (3 non-diaphyseal, 2 diaphyseal), and 1 recurrence has been seen in this
group to date. This diﬀerence is statistically signiﬁcant with a P value of .05.
1.Introduction
Osteoid osteoma is a benign osteoblastic tumour of bone.
Representing around 10% of benign bone tumours [1], these
characteristicallysmall(<2cm) lesions have a peak incidence
between childhood and early adulthood.
Osteoid osteomas may be investigated using a number of
radiographic modalities. Plain ﬁlms characteristically show
dense, fusiform, eccentric cortical sclerosis with a central,
radiolucent “nidus.” The nidus may be obscured by the
sclerosis or have undergone ossiﬁcation itself.
Tc-99 radio nucleotide bone scan may show increased
uptake in the lesion. Fine slice CT scanning with bone
windows is regarded as the “Gold-Standard” radiographic
investigation [2] (see Figure 1). MRI has been shown to be
helpful, particularly for lesions in medullary or periarticular
locations and to demonstrate peritumoural oedema [3].
These lesions have been reported to undergo sponta-
neous regression after a number of years [4] although this
is not assured and many patients ﬁnd long-term treatment
with nonsteroidal anti-inﬂammatory drugs unacceptable.
Historically the treatment of osteoid osteoma has
included surgical excision; percutaneous excision under CT
guidance [5], injection with ethanol [6, 7], arthroscopic
debridement [8, 9], and laser photocoagulation [10, 11].
Increasingly PRFTC has become the treatment of choice. It
has good reported outcomes, few side eﬀects, short hospital
stays and recurrence rates comparable with those for open
surgery [12–18].
Cribb et al. showed no relationship between success
of PRFTC and patient age, duration of symptoms, size of
lesion or previous treatment. They did note, however, that
nondiaphyseal lesions were more likely to recur than those in
the diaphysis [19].
We measured impedance during PRFTC and assessed
it as a predictor of success in the treatment of osteoid
osteoma. Impedance is the measure of opposition to ﬂow
of an alternating current (AC), analogous to “resistance” in
a direct current (DC) system. It is expressed as a voltage-
current ratio for a given frequency.
Impedance rises during PRFTC as proteins are de-
natured, and the area immediately adjacent to the probe is2 Radiology Research and Practice
Figure 1: A Typical CT radiographic appearance of an osteoid
osteoma in the proximal Humerus.
desiccated. Impedance can be calculated in real time by the
radiofrequency generator.
2.MaterialsandMethods
23 patients with osteoid osteoma were treated by CT-guided
PRFTCattheRobertJonesandAgnesHuntOrthopaedicand
DistrictHospital,Oswestry.Therewasamalepreponderance
with 15 male and 8 female patients. All patients were
investigated with plain radiographs and CT. In some patients
MRI scanning and/or radionucleotide bone scanning was
also performed. The diagnosis was made by a specialist
multidisciplinary team including musculoskeletal radiolo-
gists, orthopaedic oncological surgeons, and musculoskeletal
pathologists. Histological conﬁrmation of the diagnosis of
osteoid osteoma is not thought to be necessary owing to the
diagnostic speciﬁcity of the clinical and radiological features
[20]. Patients in whom there was debate about the diagnosis
were excluded from this study.
Of the 23 osteoid osteomas treated, 16 were nondiaphy-
seal, and 7 were diaphyseal.
The PRFTC procedures were performed in the CT
scanning suite (Figure 3), under general anaesthetic, by
a consultant musculoskeletal radiologist and a consultant
orthopaedic oncological surgeon. The lesions were located
by ﬁne (3mm) cuts. A Bonopty needle (Radi Medical
Systems, Uppsala, Sweden) was inserted under CT guidance
into the lesion to take biopsies for histological examination
and microbiological cultures. The radiofrequency electrode
(RITA Starburst—RITA Medical Systems, Mountain View,
Calif. USA) was placed within the lesion under CT control.
A radiofrequency generator (RITA generator, RITA Medical
Systems Atlanta, GA, USA) was then used to raise the
temperature of the lesion to 90◦C for 4 minutes in each
case. For lesions in which the nidus was smaller than 1cm, a
single electrode position was used, for larger lesions multiple
needle positions were used—sometimes utilising a separate
approach.
All patients were allowed home the day following the
procedure with no restrictions on activity or weight bearing.
Followupwasforameanof3.3years(range2.25–4.87years).
Followup was clinical, and symptomatic patients under-
went a further cycle of radiological investigation. Asymp-
tomatic patients did not undergo further radiological inves-
tigation.
2.1. Statistical Methods. Univariate statistical analysis was
performed using Satview for Windows (version 5, SAS
Institute). The Chi-Squared test was used to compare
recurrence rates between the groups with and without a rise
in impedance.
3. Results
In 18 procedures an increase in impedance was measured—
no recurrences have occurred in this group to date. In 5 pro-
ceduresnoincreaseinimpedancewasseen(3nondiaphyseal,
2 diaphyseal).
There was a single local recurrence. This was in a
nondiaphyseal lesion in which no rise in impedance had
been measured. This occurred 11 months after the PRFTC.
A second attempt at PRFTC was successful. At the second
p r o c e d u r ea ni n c r e a s ei ni m p e d a n c ew a so b s e r v e d( s e e
Figure 2).
The success rate in the group in which an increase in
impedance was measured was 100% and in the group in
which no increase in impedance was measured was 80% (4
out of 5).
ChiSquaredtestbetweenthegroupswithandwithoutan
observed impedance rise (for incidence of recurrence) shows
a statistically signiﬁcant diﬀerence with a P value of .05.
The average increase in impedance for diaphyseal lesions
was nearly twice that observed for nondiaphyseal lesions.
4. Discussion
Numerous studies exist showing excellent results for the
treatment of Osteoid Osteoma with Percutaneous Radiofre-
quency Ablation [12–18]. It is widely regarded as the
“Gold-Standard” for the treatment of these lesions although
reported success from the primary procedure varies between
77 and 100% [21].
Our overall success rate, in this study, was 96% (23 out of
24). This fell to 80% (4 out of 5) in those procedures where
no rise in impedance was observed.
To date the only factor predicting outcome from PRFTC
has been anatomical location (diaphyseal versus metaphy-
seal) [16, 19], and no literature exists, to our knowledge,
exploring rise in impedance as a predictive factor (Table 1).
Wefoundasigniﬁcantlygreaterriseinimpedanceduring
the procedure in those lesions located in the diaphysis of
a bone. We postulate that such lesions are often better
“contained” by the surrounding cortex and cortical reaction.
Furthermore, diaphyseal lesions are likely to have a less rich
bloodsupplycomparedtothoseinthemetaphysis.Itislikely,Radiology Research and Practice 3
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Figure 2: Graphs of probe temperature and impedance against time (a) with no observed rise in impedance and (b) same patient, repeat
procedure with observed rise in impedance.
Table 1: Impedance change during PRFTC procedures according to anatomical location.
Average start impedance (Ω)A v e r a g e e n d i m p e d a n c e ( Ω) Average increase (Ω) Average % increase
Overall 345 493 173 58%
Nondiaphyseal 321 412 203 37%
Diaphyseal 477 524 113 65%4 Radiology Research and Practice
Figure3:PositioningtheradiofrequencyprobeunderCTguidance.
therefore, that the metaphyseal locations have signiﬁcant
cooling eﬀects from circulating blood reducing the eﬃcacy
of the treatment. Although the probe tip temperature (as
controlled by the radiofrequency generator) will have been
consistent, the gradient of temperature away from the
probe may be steeper. The diminished change in impedance
therefore represents a smaller treated area, and this may help
to explain the higher risk of recurrence in nondiaphyseal
locations.
We ﬁnd it useful to monitor impedance during PRFTC
of osteoid osteomas. Impedance is calculated in real time by
the majority of radiofrequency generators, and we propose
its routine use. Where a rise in impedance is not achieved,
repositioning of the electrode and additional cycles of
treatment may be indicated.
References
[ 1 ]J .L .B l o e ma n dH .M .K r o o n ,“ O s s e o u sl e s i o n s , ”Radiologic
Clinics of North America, vol. 31, no. 2, pp. 261–278, 1993.
[2] J. Assoun, G. Richardi, J.-J. Railhac et al., “Osteoid osteoma:
MR imaging versus CT,” Radiology, vol. 191, no. 1, pp. 217–
223, 1994.
[3] A. R. Spouge and L. M. F. Thain, “Osteoid osteoma: MR
imaging revisited,” Clinical Imaging, vol. 24, no. 1, pp. 19–27,
2000.
[4] R. J. Simm, “The natural history of osteoid osteoma,”
Australian and New Zealand Journal of Surgery, vol. 45, no. 4,
pp. 412–415, 1975.
[5] N. Sans, D. Gaiy-Fourcade, J. Assoun et al., “Osteoid osteoma:
CT-guided percutaneous resection and follow-up in 38
patients,” Radiology, vol. 212, no. 3, pp. 687–692, 1999.
[6] G. Adam, P. Keulers, D. Vorwerk, K. D. Heller, L. F¨ uzesi, and
R. W. Gunther, “The percutaneous CT-guided treatment of
osteoid osteomas: a combined procedure with a biopsy drill
and subsequent ethanol injection,” Rofo, vol. 162, no. 3, pp.
232–235, 1995.
[7] L. Sanhaji, I. S. Gharbaoui, R. E. Hassani, N. Chakir, M.
Jiddane, and N. Boukhrissi, “A new treatment of the osteoid
osteoma : the percutaneous sclerosis with ethanol under CT
guidance,” Journal de Radiologie, vol. 77, no. 1, pp. 37–40,
1996.
[8] I. Bojani´ c, D. Orli´ c, and A. Ivkovi´ c, “Arthroscopic removal of
a juxtaarticular osteoid osteoma of the talar neck,” Journal of
Foot and Ankle Surgery, vol. 42, no. 6, pp. 359–362, 2003.
[9] P. David, M. Legname, and M. Dupond, “Arthroscopic
removal of an osteoid osteoma of the talar neck,” Revue de
Chirurgie Orthopedique et Traumatologique, vol. 95, no. 6, pp.
554–557, 2009.
[10] A. Gangi, J.-L. Dietemann, B. Gasser et al., “Interstitial
laser photocoagulation of osteoid osteomas with use of CT
guidance,” Radiology, vol. 203, no. 3, pp. 843–848, 1997.
[11] A. Gangi, J.-L. Dietemann, S. Guth et al., “Percutaneous
laser photocoagulation of spinal osteoid osteomas under CT
guidance,” American Journal of Neuroradiology, vol. 19, no. 10,
pp. 1955–1958, 1998.
[12] D. I. Rosenthal, F. J. Hornicek, M. Torriani, M. C. Gebhardt,
and H. J. Mankin, “Osteoid osteoma: percutaneous treatment
with radiofrequency energy,” Radiology, vol. 229, no. 1, pp.
171–175, 2003.
[ 1 3 ]D .P .B a r e i ,G .M o r e a u ,M .T .S c a r b o r o u g h ,a n dM .D .N e e l ,
“Percutaneous radiofrequency ablation of osteoid osteoma,”
Clinical Orthopaedics and Related Research, no. 373, pp. 115–
124, 2000.
[14] I. B. Ghanem, L.-M. Collet, K. Kharrat et al., “Percutaneous
radiofrequency coagulation of osteoid osteoma in children
and adolescents,” Journal of Pediatric Orthopaedics Part B, vol.
12, no. 4, pp. 244–252, 2003.
[15] N. J. Lindner, T. Ozaki, R. Roedl, G. Gosheger, W. Winkel-
mann,andK.W¨ ortler,“Percutaneousradiofrequencyablation
in osteoid osteoma,” Journal of Bone and Joint Surgery. British,
vol. 83, no. 3, pp. 391–396, 2001.
[16] G. M. Vanderschueren, A. H. Taminiau, W. R. Obermann,
A. A. van den Berg-Huysmans, and J. L. Bloem, “Osteoid
osteoma: factors for increased risk of unsuccessful thermal
coagulation,” Radiology, vol. 233, no. 3, pp. 757–762, 2004.
[17] A. C. Venbrux, B. J. Montague, K. P. J. Murphy et al., “Image-
guided percutaneous radiofrequency ablation for osteoid
osteomas,” Journal of Vascular and Interventional Radiology,
vol. 14, no. 3, pp. 375–380, 2003.
[18] K. Woertler, T. Vestring, F. Boettner, W. Winkelmann, W.
Heindel, and N. Lindner, “Osteoid osteoma: CT-guided
percutaneous radiofrequency ablation and follow-up in 47
patients,” Journal of Vascular and Interventional Radiology, vol.
12, no. 6, pp. 717–722, 2001.
[19] G. L. Cribb, W. H. Goude, P. Cool, B. Tins, V. N. Cassar-
Pullicino, and D. C. Mangham, “Percutaneous radiofrequency
thermocoagulation of osteoid osteomas: factors aﬀecting
therapeutic outcome,” Skeletal Radiology, vol. 34, no. 11, pp.
702–706, 2005.
[20] F. H. Sim, D. C. Dahlin, and J. W. Beabout, “Osteoid osteoma:
diagnostic problems,” Journal of Bone and Joint Surgery.
American, vol. 57, no. 2, pp. 154–159, 1975.
[21] C. P. Cantwell, J. Obyrne, and S. Eustace, “Current trends
in treatment of osteoid osteoma with an emphasis on
radiofrequency ablation,” European Radiology, vol. 14, no. 4,
pp. 607–617, 2004.